Novo Nordisk AS Vs. Grifols SA Industry Stock Comparison

Sell

39

NVO
Novo Nordisk AS

Last Price:

107.09

Seasonality Move:

9.3%

Buy

55

GRFS
Grifols SA

Last Price:

9.11

Seasonality Move:

7.18%

Sell

39

Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

The current Novo Nordisk AS [NVO] share price is $109.09. The Score for NVO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
NVO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Buy

55

Grifols SA (GRFS) is a Buy

Is Grifols SA a Buy, Sell or Hold?

The current Grifols SA [GRFS] share price is $9.32. The Score for GRFS is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
GRFS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

The Novo Nordisk AS share price today is $109.09
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing selling pressure, which indicates risk of future bearish movement.

GRFS Stock Price Chart

What is Grifols SA's stock price today?

The Grifols SA share price today is $9.32
The current trend is moderately bullish and GRFS is experiencing slight buying pressure.

NVO Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-3.7	Sell
Relative Strength Index (14 RSI):	36.25	Sell
Chaikin Money Flow:	-3992643	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(109.94 - 118.12)	Sell
Bollinger Bands (100):	(117.81 - 139.27)	Sell

GRFS Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.17	Buy
Relative Strength Index (14 RSI):	59.48	Buy
Chaikin Money Flow:	91289	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(8.48 - 9.12)	Buy
Bollinger Bands (100):	(7.4 - 9.08)	Buy

NVO Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	109.13	Sell
20-day SMA:	113.06	Sell
50-day SMA:	121.23	Sell
200-day SMA:	128.28	Sell
8-day EMA:	109.23	Sell
20-day EMA:	112.5	Sell
50-day EMA:	118.99	Sell
200-day EMA:	122.09	Sell

GRFS Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	9.12	Buy
20-day SMA:	8.82	Buy
50-day SMA:	8.86	Buy
200-day SMA:	7.72	Buy
8-day EMA:	9.17	Buy
20-day EMA:	8.95	Buy
50-day EMA:	8.71	Buy
200-day EMA:	8.21	Buy

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.58 per share, and an increase next year of $0.69 per share.

Grifols SA Earnings Growth & GRFS Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and an increase next year of $0.44 per share.

Novo Nordisk AS Technical Analysis

	Oct 29	Oct 30	Oct 31	Nov 1	Nov 4	Nov 5	Nov 6	Nov 7	Nov 8	Nov 11
	Oct				Nov
	29	30	31	01	04	05	06	07	08	11
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Grifols SA Technical Analysis

	Oct 29	Oct 30	Oct 31	Nov 1	Nov 4	Nov 5	Nov 6	Nov 7	Nov 8	Nov 11
	Oct				Nov
	29	30	31	01	04	05	06	07	08	11
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):